federal_register: 2025-20658

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2025-20658 Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine; Public Workshop; Request for Comments Notice The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine." The purpose of the public workshop is to initiate a discussion on expanding epinephrine accessibility and use, including in community settings, to reduce anaphylaxis-related morbidity and mortality. This public workshop will be convened and supported by a cooperative agreement between FDA and the Duke-Margolis Institute for Health Policy. 2025-11-24 2025 11 https://www.federalregister.gov/documents/2025/11/24/2025-20658/improving-anaphylaxis-outcomes-approaches-for-enhancing-access-to-epinephrine-public-workshop https://www.govinfo.gov/content/pkg/FR-2025-11-24/pdf/2025-20658.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine." The purpose of the public workshop is to initiate a...  

Links from other tables